Yuanyuan An
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuanyuan An has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Fengtian Liu
Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, Shenyang, P.R. China
1 shared publication- Qing Yang
Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China
1 shared publication Ying Chen
Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, Shenyang, P.R. China
1 shared publication
Latest Publications
- Open Access
- 23 October 2019
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (1) , 13-24
Crosstalk between cancer‐associated fibroblasts and immune cells in cancer
Multiple studies have shown that cancer‐associated fibroblasts (CAFs) play an important role in tumour progression, including carcinogenesis, invasion, metastasis and the chemoresistance of cancer cells. Immune cells, including macrophages, natural killer cells, dendritic cells and T cells, play a dual role in the tumour microenvironment. Although increasing research has focused on studying interactions between distinct cells in the tumour microenvironment, the complex relationships between CAFs and immune cells remain unclear and need further study. Here, we summarize our current understanding of crosstalk between CAFs and immune cells, which may help clarify their diagnostic and therapeutic value in tumour progression.
- 23 October 2019
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (1) , 13-24
Open AccessCrosstalk between cancer‐associated fibroblasts and immune cells in cancer
Multiple studies have shown that cancer‐associated fibroblasts (CAFs) play an important role in tumour progression, including carcinogenesis, invasion, metastasis and the chemoresistance of cancer cells. Immune cells, including macrophages, natural killer cells, dendritic cells and T cells, play a dual role in the tumour microenvironment. Although increasing research has focused on studying interactions between distinct cells in the tumour microenvironment, the complex relationships between CAFs and immune cells remain unclear and need further study. Here, we summarize our current understanding of crosstalk between CAFs and immune cells, which may help clarify their diagnostic and therapeutic value in tumour progression.